We published a 12-page Quarterly Update on specialty biopharmaceutical company Aeterna Zentaris, Inc. this morning. The report updates readers on Aeterna's news, milestones, and clinical and commercial development status since the publication of our base report, the Executive Informational Overview from April 2015.